What is bv infection

Understanding BV Infection

A bacterial vaginosis (BV) infection represents a disruption of the vaginal microecosystem. The healthy vagina maintains a delicate balance of microorganisms, dominated by Lactobacillus species that produce lactic acid. This acidic environment (pH 3.8-4.5) naturally suppresses the growth of harmful bacteria. BV infection occurs when this balance is disrupted, allowing pathogenic bacteria to proliferate.

Infection Mechanism

In a BV infection, the population of beneficial Lactobacillus bacteria dramatically decreases, and their place is taken by anaerobic bacteria including Gardnerella vaginalis, Prevotella species, and Mycoplasma. These bacteria produce compounds called biogenic amines that cause the characteristic fishy odor. The loss of lactic acid production causes vaginal pH to rise, further promoting pathogenic bacterial growth and creating a self-perpetuating cycle.

Infection Symptoms

Women with BV infection typically experience one or more of the following:

• Vaginal discharge: Thin, homogeneous discharge with gray, white, or greenish color
• Odor: Strong fishy smell that intensifies after sexual intercourse
• Itching and burning: Vaginal irritation and discomfort during urination
• Pelvic pain: Mild discomfort in the lower abdomen or pelvis

Approximately 50% of women with BV infection are asymptomatic and discover the condition only during routine medical examination.

Diagnosis

Healthcare providers diagnose BV infection using clinical criteria and laboratory testing. Amsel's criteria require three of four findings: abnormal discharge, elevated vaginal pH (>4.5), positive whiff test (fishy odor when discharge is mixed with potassium hydroxide), and presence of clue cells on microscopy. Nucleic acid amplification tests (NAATs) provide highly sensitive and specific diagnosis.

Treatment of BV Infection

BV infection responds well to antibiotic therapy with cure rates exceeding 90%. First-line treatments include:

• Metronidazole: Oral (500 mg twice daily for 7 days) or vaginal gel (0.75% once daily for 5 days)
• Clindamycin: Oral (300 mg twice daily for 7 days) or vaginal cream (2% once daily for 7 days)
• Tinidazole: Oral (2g once daily for 2 days) as an alternative option

Complications and Prevention

Untreated BV infection carries significant health risks. It increases susceptibility to sexually transmitted infections by 3-5 fold and can progress to pelvic inflammatory disease, endometritis, and tubo-ovarian abscess. In pregnant women, untreated BV infection substantially increases risk of preterm delivery and low birth weight. Prevention includes avoiding douching, limiting sexual partners, practicing safer sex, and maintaining vaginal health.